INR 337.35
(-0.41%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 18.17 Billion INR | 10.81% |
2022 | 16.4 Billion INR | 9.06% |
2021 | 15.03 Billion INR | 23.4% |
2020 | 12.18 Billion INR | 12.84% |
2019 | 10.79 Billion INR | 14.64% |
2018 | 9.42 Billion INR | -7.43% |
2017 | 10.17 Billion INR | -7.21% |
2016 | 10.96 Billion INR | 9.27% |
2015 | 10.03 Billion INR | 17.13% |
2014 | 8.56 Billion INR | 16.97% |
2013 | 7.32 Billion INR | 16.21% |
2012 | 6.3 Billion INR | 10.83% |
2011 | 5.68 Billion INR | 17.62% |
2010 | 4.83 Billion INR | 21.41% |
2009 | 3.98 Billion INR | 51.62% |
2008 | 2.62 Billion INR | 0.0% |
2007 | - INR | -100.0% |
2006 | 3.25 Billion INR | 33.92% |
2005 | 2.43 Billion INR | 25.38% |
2004 | 1.94 Billion INR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 4.3 Billion INR | 0.27% |
2024 Q1 | 4.31 Billion INR | -4.04% |
2023 Q2 | 4.73 Billion INR | 13.62% |
2023 Q4 | 4.49 Billion INR | -1.99% |
2023 Q3 | 4.58 Billion INR | -3.13% |
2023 FY | 18.17 Billion INR | 10.81% |
2023 Q1 | 4.16 Billion INR | -2.78% |
2022 Q2 | 4.04 Billion INR | 2.46% |
2022 Q1 | 3.95 Billion INR | -1.33% |
2022 FY | 16.4 Billion INR | 9.06% |
2022 Q4 | 4.28 Billion INR | 4.28% |
2022 Q3 | 4.11 Billion INR | 1.53% |
2021 Q2 | 3.72 Billion INR | -2.23% |
2021 Q1 | 3.81 Billion INR | 29.26% |
2021 FY | 15.03 Billion INR | 23.4% |
2021 Q3 | 3.48 Billion INR | -6.45% |
2021 Q4 | 4 Billion INR | 14.8% |
2020 FY | 12.18 Billion INR | 12.84% |
2020 Q2 | 3.23 Billion INR | 21.08% |
2020 Q1 | 2.66 Billion INR | 1.39% |
2020 Q4 | 2.95 Billion INR | -11.56% |
2020 Q3 | 3.33 Billion INR | 3.28% |
2019 Q2 | 2.86 Billion INR | 15.79% |
2019 FY | 10.79 Billion INR | 14.64% |
2019 Q4 | 2.63 Billion INR | -7.17% |
2019 Q3 | 2.83 Billion INR | -0.96% |
2019 Q1 | 2.47 Billion INR | 0.89% |
2018 FY | 9.42 Billion INR | -7.43% |
2018 Q2 | 2.36 Billion INR | 11.05% |
2018 Q1 | 2.12 Billion INR | 0.0% |
2018 Q3 | 2.48 Billion INR | 5.0% |
2018 Q4 | 2.44 Billion INR | -1.24% |
2017 FY | 10.17 Billion INR | -7.21% |
2016 FY | 10.96 Billion INR | 9.27% |
2015 FY | 10.03 Billion INR | 17.13% |
2014 Q1 | 1.98 Billion INR | 0.0% |
2014 FY | 8.56 Billion INR | 16.97% |
2013 FY | 7.32 Billion INR | 16.21% |
2013 Q1 | 1.53 Billion INR | -6.6% |
2012 Q3 | 1.5 Billion INR | 0.0% |
2012 FY | 6.3 Billion INR | 10.83% |
2012 Q4 | 1.64 Billion INR | 9.71% |
2011 FY | 5.68 Billion INR | 17.62% |
2010 FY | 4.83 Billion INR | 21.41% |
2009 FY | 3.98 Billion INR | 51.62% |
2008 FY | 2.62 Billion INR | 0.0% |
2007 FY | - INR | -100.0% |
2006 FY | 3.25 Billion INR | 33.92% |
2005 FY | 2.43 Billion INR | 25.38% |
2004 FY | 1.94 Billion INR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Sigachi Industries Limited | 3.98 Billion INR | -355.511% |
Ind-Swift Limited | 5.02 Billion INR | -261.673% |
Bajaj HealthCare Limited | 4.73 Billion INR | -283.866% |
Sakar Healthcare Limited | 1.54 Billion INR | -1078.778% |
Aurobindo Pharma Limited | 290.01 Billion INR | 93.734% |
Innova Captab Limited | 10.81 Billion INR | -68.065% |
Divi's Laboratories Limited | 78.45 Billion INR | 76.835% |
AstraZeneca Pharma India Limited | 12.95 Billion INR | -40.274% |
Morepen Laboratories Limited | 17.01 Billion INR | -6.78% |
Mankind Pharma Limited | 103.34 Billion INR | 82.416% |
Sequent Scientific Limited | 13.69 Billion INR | -32.675% |
Wanbury Limited | 5.75 Billion INR | -215.694% |
Laurus Labs Limited | 50.01 Billion INR | 63.667% |
Nectar Lifesciences Limited | 16.84 Billion INR | -7.879% |
Glenmark Life Sciences Limited | 22.83 Billion INR | 20.406% |
Alembic Limited | 1.57 Billion INR | -1053.943% |
Hikal Limited | 17.84 Billion INR | -1.832% |
Alembic Pharmaceuticals Limited | 61.12 Billion INR | 70.267% |
Neuland Laboratories Limited | 15.58 Billion INR | -16.599% |
J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | 47.289% |
Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 84.616% |
IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | 14.793% |
Themis Medicare Limited | 3.81 Billion INR | -376.028% |
RPG Life Sciences Limited | 5.82 Billion INR | -212.222% |
Zydus Lifesciences Limited | 190.21 Billion INR | 90.446% |
Lupin Limited | 196.56 Billion INR | 90.755% |
Amrutanjan Health Care Limited | 4.21 Billion INR | -331.424% |
Wockhardt Limited | 27.89 Billion INR | 34.841% |
Vaishali Pharma Limited | 862.79 Million INR | -2006.278% |
Aarti Pharmalabs Limited | 18.15 Billion INR | -0.098% |
Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -770.758% |
Jubilant Pharmova Limited | 67.02 Billion INR | 72.888% |
FDC Limited | 19.42 Billion INR | 6.467% |
Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 93.49% |
Kilitch Drugs (India) Limited | 1.54 Billion INR | -1077.211% |
Eris Lifesciences Limited | 20.09 Billion INR | 9.549% |
Venus Remedies Limited | 5.91 Billion INR | -207.26% |
ZIM Laboratories Limited | 3.67 Billion INR | -394.478% |
Bliss GVS Pharma Limited | 7.7 Billion INR | -135.937% |
Par Drugs and Chemicals Limited | 956.4 Million INR | -1800.128% |
Caplin Point Laboratories Limited | 16.76 Billion INR | -8.38% |
Shilpa Medicare Limited | 11.53 Billion INR | -57.599% |
Albert David Limited | 3.62 Billion INR | -401.374% |
Ajanta Pharma Limited | 42.08 Billion INR | 56.821% |
Hester Biosciences Limited | 3.04 Billion INR | -496.721% |
Suven Pharmaceuticals Limited | 10.51 Billion INR | -72.852% |
Solara Active Pharma Sciences Limited | 12.38 Billion INR | -46.746% |
Gufic Biosciences Limited | 8.06 Billion INR | -125.284% |
Windlas Biotech Limited | 6.3 Billion INR | -188.022% |
Procter & Gamble Health Limited | 11.51 Billion INR | -57.852% |
Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -359.355% |
Mangalam Drugs & Organics Limited | 3.67 Billion INR | -394.698% |
Granules India Limited | 45.06 Billion INR | 59.673% |
Aarti Drugs Limited | 25.28 Billion INR | 28.13% |
Bal Pharma Limited | 3.39 Billion INR | -435.727% |
Alkem Laboratories Limited | 126.67 Billion INR | 85.654% |
Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 96.253% |
Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -213.029% |
Medicamen Biotech Limited | 1.79 Billion INR | -913.512% |
Unichem Laboratories Limited | 16.57 Billion INR | -9.646% |
Bafna Pharmaceuticals Limited | 1.52 Billion INR | -1091.934% |
Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -4439.219% |
Valiant Laboratories Limited | 1.82 Billion INR | -898.197% |
Orchid Pharma Limited | 8.19 Billion INR | -121.792% |
Medico Remedies Limited | 1.44 Billion INR | -1153.989% |
Ind-Swift Laboratories Limited | 12.8 Billion INR | -41.876% |
Ipca Laboratories Limited | 77.05 Billion INR | 76.417% |
Brooks Laboratories Limited | 794.86 Million INR | -2186.299% |
Syncom Formulations (India) Limited | 2.59 Billion INR | -600.996% |
Piramal Enterprises Limited | 60.33 Billion INR | 69.881% |
Torrent Pharmaceuticals Limited | 106.05 Billion INR | 82.865% |
NATCO Pharma Limited | 40.02 Billion INR | 54.59% |
Suven Life Sciences Limited | 116.92 Million INR | -15441.825% |
Krebs Biochemicals & Industries Limited | 504.21 Million INR | -3504.197% |
Strides Pharma Science Limited | 40.51 Billion INR | 55.141% |
Alpa Laboratories Limited | 1.08 Billion INR | -1571.24% |
Lasa Supergenerics Limited | 1.04 Billion INR | -1641.784% |
Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -2305.563% |